STSA-1005

N/A

Report date: 2024/06/04 16:17:15

Base Information

Drug NameSTSA-1005
Drug Alias NameSTSA-1005STSA1005
ClassificationBiologics
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor subunit alpha inhibitors
TargetsGranulocyte-macrophage colony-stimulating factor receptor subunit alpha
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStaidson BioPharma Inc
Inactive CompaniesStaidson(Beijing) Biopharmaceuticals Co Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A